Table 3. Incremental cost-effectiveness of a subset of diagnostic procedures for Pneumocystis pneumonia, assuming 50% disease prevalence.
Specimen collection and diagnostic procedure | % of patients successfully treated | Average cost per life-year gained | Cost per additional life-year gained, compared with next-least-effective procedure |
IS/TBO | 0.68 | $25 | $N/A |
ES/nPCR | 0.82 | $28 | $43 |
ES/rtPCR | 0.83 | $36 | $804 |
IS/PCR | 0.85 | $39 | $156 |
IS/nPCR | 0.90 | $40 | $60 |
IS: Induced sputum; ES: expectorated sputum; TBO: Toluidine Blue O; PCR: polymerase chain reaction; nPCR: nested PCR; rtPCR: real-time (quantitative) PCR.